Posts by Michele Gadd, MD
-
Novel Intraoperative Fluorescence Guidance Identifies Residual Tumor During Lumpectomy
Barbara Smith, MD, PhD, Michelle Gadd, MD and colleagues showed in a prospective, multicenter trial that a novel pegulicianine fluorescence-guided system, designed to allow intraoperative assessment of lumpectomy cavity margins and repeat shaves, facilitates removal of tumor left behind after standard surgery.
Biography
Michele Gadd, MD, is an assistant professor of Surgery at Harvard Medical School and an associate visiting surgeon at Massachusetts General Hospital. Dr. Gadd received her undergraduate training at Bucknell University in Pennsylvania, and her Medical Degree from Pennsylvania State University. Dr. Gadd completed a surgical residency at the University of California - San Diego, and then a Surgical Oncology Fellowship at Memorial Sloan-Kettering Cancer Center in New York.
Dr. Gadd's research activities have focused on reducing the extent of axillary surgery required to treat breast cancer, on improving the cosmetic results of treatment and on quality improvement in breast cancer care.
Dr. Gadd works in a multidisciplinary breast cancer setting, teaches at the medical school and participates in breast cancer related clinical research activities.
Mass General Cancer Center
An integral part of one of the world’s most distinguished academic medical centers, the Massachusetts General Hospital Cancer Center is among the leading cancer care providers in the United States.
